RxDoctor Payments Data

Florie Ann Gonsch, DO

Internal Medicine · Palos Heights, ILNPI 1831144476

Payments from drug & device makers

$440in general payments, 2019–2025

Across 22 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$188
  • Pfizer$160
  • AbbVie$32
  • Boehringer Ingelheim$20
  • Novo Nordisk$17
  • Mylan Specialty L.p.$12
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$440 in reported general payments places this provider in the 65th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$218,865
Medicare patients
423
Services billed
2,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban71$69,419
JanuviaSitagliptin Phosphate28$35,700
OzempicSemaglutide19$27,314
XareltoRivaroxaban18$21,928
TrulicityDulaglutide16$21,127
TradjentaLinagliptin12$9,319
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,414
Levothyroxine Sodium420$5,305
Atorvastatin Calcium478$4,744
Losartan Potassium394$4,590
Metoprolol Succinate258$4,522
SynthroidLevothyroxine Sodium51$3,886
Amlodipine Besylate391$3,063
Potassium Chloride97$2,361
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$160$69,41971 claims
Novo NordiskOzempic$17$27,31419 claims
Lilly USA, LLCTrulicity$11$21,12716 claims
Boehringer IngelheimTradjenta$20$9,31912 claims
AbbVieSynthroid$32$3,88651 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Palos Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →